1529-0131a/asset/cover.gif?v=1&s=4b71f39689e424fbb0e6725b1c033cc646a4272b "Arthritis Care & Research")
Direct Link:
2151-4658/asset/olbannerleft.gif?v=1&s=75d1dd4933b4687fdb365bb32190b0a4ef453ee7)
2151-4658/asset/olbannerright.gif?v=1&s=a36ba6af41bd9af370864f6461a516746a709d31)
Health Services Research
You have full text access to this OnlineOpen article
Impact of medicare part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis
Article first published online: 28 MAY 2009
DOI: 10.1002/art.24560
Copyright © 2009 by the American College of Rheumatology
Additional Information
How to Cite
Polinski, J. M., Mohr, P. E. and Johnson, L. (2009), Impact of medicare part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis. Arthritis & Rheumatism, 61: 745–754. doi: 10.1002/art.24560
Publication History
- Issue published online: 28 MAY 2009
- Article first published online: 28 MAY 2009
- Manuscript Accepted: 25 FEB 2009
- Manuscript Received: 25 AUG 2008
REFERENCES
- 1, , , , , , et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008; 59: 762–84.
- 2, , , , , , et al. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess 2006; 10: 1–229.
- 3. The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence. Curr Opin Rheumatol 2007; 19: 308–13.
- 4. Insurers' strategies for managing the use and cost of biopharmaceuticals. Health Aff (Millwood) 2006; 25: 1205–17.
- 5, , , , . Benefit design and specialty drug use. Health Aff (Millwood) 2006; 25: 1319–31.
- 6, , , , . Health plans' strategies for managing outpatient specialty pharmaceuticals. Health Aff (Millwood) 2006; 25: 1332–9.
- 7, Secretary of Health and Human Services. Report to Congress: evaluation of the Medicare replacement drug demonstration. 2007. URL: http://www.cms.hhs.gov/DemoProjectsEvalRpts/downloads/MMA641_RTC.pdf.
- 8Centers for Medicare and Medicaid Services. Medicare program: Medicare prescription drug benefit. Final rule: interpretation. Fed Regist 2005; 70: 13397–400.
- 9Department of Health and Human Services, Centers for Medicare and Medicaid Services. Medicare prescription drug benefit manual: chapter 6. Part D drugs and formulary requirements. URL: http://www.cms.hhs.gov/PrescriptionDrugCovContra/Downloads/R2PDB.pdf.
- 10, , , . An in-depth examination of formularies and other features of Medicare drug plans. URL: http://www.kff.org/medicare/7489.cfm.
- 11, , , . Medicare Part D 2008 data spotlight: specialty tiers. URL: http://www.kff.org/medicare/upload/7711.pdf.
- 12Centers for Medicare and Medicaid Services. The Medicare replacement drug demonstration evaluation report. URL: http://www.cms.hhs.gov/DemoProjectsEvalRpts/downloads/MMA641_Demo_Evaluation_p.pdf.
- 13, , , , , , et al. Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev 2004; 25: 119–41.
- 14, , . Diagnosis-based risk adjustment for Medicare prescription drug plan payments. Health Care Financ Rev 2007; 28: 15–30.
- 15US Census Bureau. Summary file 1: 2000 census of population and housing. URL: http://www.census.gov/prod/cen2000/doc/sf1.pdf.
- 16US Department of Health and Human Services, Health Resources and Services Administration. Area resource file: national county-level health resource information database. URL: http://arfsys.com/index.htm.
- 17Kaiser Family Foundation. The Medicare prescription drug benefit. URL: http://www.kff.org/medicare/upload/7044-04.pdf.
- 18Centers for Medicare and Medicaid Services. Prescription drug plan formulary and pharmacy network files and prescription drug coverage files. 2006. URL: http://www.cms.hhs.gov/nonidentifiabledatafiles/09_prescriptiondrugplanformulary,pharmacynetwork,andpricinginformationfiles.asp.
- 19Centers for Medicare and Medicaid Services. Prescription drug coverage files. 2006. URL: http://www.cms.hhs.gov/prescriptiondrugcovgenin/.
- 20US Department of Health and Human Services. Over 38 million people with Medicare now receiving prescription drug coverage. 2006. URL: http://hhs.gov/news/press/2006pres/20060614.html.
- 21. Molecular medicine, the Medicare drug benefit, and the need for cost control. J Am Geriatr Soc 2006; 54: 1442–6.Direct Link:
- 22. Co-payments for expensive drugs soar. The New York Times 2008 April 14. URL: http://www.nytimes.com/2008/04/14/us/14drug.html?emc=eta1.
- 23, . Tier 4 drugs and the fraying of the social compact. N Engl J Med 2008; 359: 333–5.
- 24, , , , , , et al. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med 2006; 166: 332–7.